Capital Flow Monitor · Sponsors · CIK 2108983
Caradon Therapeutics, Inc.
1281 HYMETTUS AVE., ENCINITAS, CA, 92024 · (619) 990-0290
Biotechnology · Corporation· inc. DELAWARE true 2023
Fit score
—
Offering
$900K
Sold
$559K
% sold
62.1%
Investors
7
Min investment
$0
Exemption
506(b)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2026-02-03 | D ·current | 506(b) | $900K | $559K | 62.1% | 7 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed. Other raises are matched by exact name and show amount sold as last reported.
-
Brian Laurence Johnson — Executive Officer / Director, Encinitas, CA
1 other raise
- Antlia Bioscience, Inc. $6.0M of $20.0M · 30.0%
Placement agents
- No sales compensation reported — direct raise.
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.